These results suggest that both systemic Inflammatory status and treatment-related immunomodulation may affect the outcome of these patients a finding that highlight a possible involvement of immunesystem in ultimate antitumor effect of this regimen, and offer a solid rationale to test our metronomic regimen in a module of sequential combination with anti-PD-1/PDL-1 inhibitors.

Pastina, P., Nardone, V., Battaglia, G., Botta, C., Tini, P., Bellan, C., et al. (2017). Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab. JOURNAL OF THORACIC ONCOLOGY, 12(Supplement 1), S921-S921 [10.1016/j.jtho.2016.11.1263].

Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab

Pierpaolo Pastina;Valerio Nardone;Battaglia Giuseppe;Cirino Botta;Paolo Tini;Cristiana Bellan;Veronica Ricci;Marcella Barbarino;Stefania Croci;Michele Caraglia;Antonio Giordano;Maria Grazia Cusi;Luigi Pirtoli;
2017-01-01

Abstract

These results suggest that both systemic Inflammatory status and treatment-related immunomodulation may affect the outcome of these patients a finding that highlight a possible involvement of immunesystem in ultimate antitumor effect of this regimen, and offer a solid rationale to test our metronomic regimen in a module of sequential combination with anti-PD-1/PDL-1 inhibitors.
2017
Pastina, P., Nardone, V., Battaglia, G., Botta, C., Tini, P., Bellan, C., et al. (2017). Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab. JOURNAL OF THORACIC ONCOLOGY, 12(Supplement 1), S921-S921 [10.1016/j.jtho.2016.11.1263].
File in questo prodotto:
File Dimensione Formato  
Abstract .pdf

non disponibili

Tipologia: PDF editoriale
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 95.2 kB
Formato Adobe PDF
95.2 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1056889